ASYS vs LRCX

For growth investors, Lam Research Corporation (LRCX) is the stronger pick with 23.

7% revenue growth year-over-year, versus -21. 6% for Amtech Systems, Inc. (ASYS). Lam Research Corporation (LRCX) offers the better valuation at 70. 9x trailing P/E (51. 8x forward), making it the more compelling value choice. Analysts rate Amtech Systems, Inc. (ASYS) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Lam Research Corporation is actually cheaper at 51.

8x.

Over the past 5 years, Lam Research Corporation (LRCX) delivered a total return of +408.

0%, compared to +125. 5% for Amtech Systems, Inc. (ASYS). Over 10 years, the gap is even starker: LRCX returned +39. 2% versus ASYS's +257. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Amtech Systems, Inc.

(ASYS) is the lower-risk stock at 1. 84β versus Lam Research Corporation's 2. 61β — meaning LRCX is approximately 42% more volatile than ASYS relative to the S&P 500. On balance sheet safety, Amtech Systems, Inc. (ASYS) carries a lower debt/equity ratio of 37% versus 48% for Lam Research Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Lam Research Corporation (LRCX) is pulling ahead at 23.

7% versus -21. 6% for Amtech Systems, Inc. (ASYS). On earnings-per-share growth, the picture is similar: Lam Research Corporation grew EPS 43. 1% year-over-year, compared to -253. 3% for Amtech Systems, Inc.. Over a 3-year CAGR, LRCX leads at 2. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Lam Research Corporation (LRCX) is the more profitable company, earning 29.

1% net margin versus -38. 2% for Amtech Systems, Inc. — meaning it keeps 29. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LRCX leads at 32. 0% versus -35. 9% for ASYS. At the gross margin level — before operating expenses — LRCX leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Lam Research Corporation (LRCX) trades at 51.

8x forward P/E versus 67. 2x for Amtech Systems, Inc. — 15. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ASYS: 2. 4% to $22. 00.

In this comparison, LRCX (0.

3% yield) pays a dividend. ASYS does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Amtech Systems, Inc.

(ASYS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+257. 0% 10Y return). Lam Research Corporation (LRCX) carries a higher beta of 2. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ASYS: +257. 0%, LRCX: +39. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ASYS is a small-cap quality compounder stock; LRCX is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.